Here’s what to expect when Disney reports earnings before the bell

Here’s what to expect when Disney reports earnings before the bell


Daytime fireworks launch over Cinderella Castle during a performance of “Mickey’s Magical Friendship Faire” in the Magic Kingdom at Walt Disney World, Bay Lake, Florida, April 30, 2024. (Joe Burbank/Orlando Sentinel/Tribune News Service via Getty Images)

Orlando Sentinel | Tribune News Service | Getty Images

Disney will report its fiscal second-quarter earnings before the bell on Wednesday, and Wall Street will be paying close attention to the state of its streaming and theme parks businesses.

Investors will also be listening for any details on the search for CEO Bob Iger’s successor.

Here is what Wall Street expects Disney to report on Wednesday, according to analysts polled by LSEG:

  • Earnings per share: $1.20
  • Revenue: $23.14 billion

Last quarter, the company beat on the top and bottom lines, but revealed the beginnings of expected streaming subscriber losses at Disney+.

Disney warned during its fiscal fourth-quarter report in November that it expected a “modest decline” in subscriptions during the December period. It told investors during February’s earnings report that it expected another “modest decline” in subscribers during its fiscal second quarter. 

The slowdown in streaming subscriber growth follows an increase in prices for its services last year. 

Eyes will also be on its experience segment, which includes theme parks. The division performed better than expected in the fiscal first-quarter, but travel experts have warned about waning international travelers and a potential traffic decrease as a result of President Donald Trump’s tariffs.

Theme parks in the U.S. have generally experienced a slowdown in foot traffic following the post-Covid surge in attendance.

This story is developing. Please check back for updates.



Source

FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More
Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war
Business

Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war

Toyota Motor Corp. vehicles bound for shipment at the Port of Nagoya in Tokai, Aichi Prefecture, Japan, on Tuesday, April 29, 2025. Toru Hanai | Bloomberg | Getty Images DETROIT — Toyota Motor, Hyundai Motor and Chinese automakers such as Chery face the most potential impact of non-domestic automakers from the U.S.-Israel war with Iran, […]

Read More
Used vehicle prices jump ahead of spring selling season optimism
Business

Used vehicle prices jump ahead of spring selling season optimism

A used car dealership is seen in Annapolis, Maryland on May 27, 2021, as many car dealerships across the country are running low on new vehicles as a computer chip shortage has caused production at many vehicle manufactures to nearly stop. Jim Watson | AFP | Getty Images DETROIT — A closely watched barometer for used […]

Read More